BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oxford Society of Ageing and Longevity - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oxford Society of Ageing and Longevity
X-ORIGINAL-URL:https://www.ageingandlongevity.org
X-WR-CALDESC:Events for Oxford Society of Ageing and Longevity
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260204T190000
DTEND;TZID=UTC:20260204T190000
DTSTAMP:20260608T191537
CREATED:20260202T213259Z
LAST-MODIFIED:20260202T213340Z
UID:1199-1770231600-1770231600@www.ageingandlongevity.org
SUMMARY:Rehydration OSAL's Welcome Social
DESCRIPTION:Join us for our first social of the year to get to know members of the society and what other events we have in store this term!
URL:https://www.ageingandlongevity.org/event/rehydration-osals-welcome-social/
LOCATION:Jesus College Bar\, Turl Street\, Oxford\, OX1 3DW
ATTACH;FMTTYPE=image/jpeg:https://www.ageingandlongevity.org/wp-content/uploads/2026/02/rehydration.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260216T180000
DTEND;TZID=UTC:20260216T180000
DTSTAMP:20260608T191537
CREATED:20260210T150858Z
LAST-MODIFIED:20260210T150920Z
UID:1206-1771264800-1771264800@www.ageingandlongevity.org
SUMMARY:Genflow Biosciences: Translating longevity research to the bedside
DESCRIPTION:Dr. Eric Leire is the Founder and CEO of Genflow Biosciences\, a longevity gene therapy company listed on the London Stock Exchange. An MD and MBA (HEC/Kellogg)\, he combines research experience from the Harvard AIDS Institute with executive leadership at Pfizer and Biofund Venture Capital. Dr. Leire has guided multiple biotech companies to public listings (Nasdaq) and holds several pharmaceutical patents.
URL:https://www.ageingandlongevity.org/event/genflow-biosciences-translating-longevity-research-to-the-bedside/
LOCATION:David Smith Lecture Theatre Department of Pharmacology Mansfield Road Oxford OX1 3QT United Kingdom\, David Smith Lecture Theatre Department of Pharmacology Mansfield Road\, Oxford United Kingdom\, OX1 3QT\, United Kingdom
ATTACH;FMTTYPE=image/png:https://www.ageingandlongevity.org/wp-content/uploads/2026/02/GenflowBiosciences.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260310T180000
DTEND;TZID=UTC:20260310T180000
DTSTAMP:20260608T191537
CREATED:20260305T171932Z
LAST-MODIFIED:20260305T172025Z
UID:1221-1773165600-1773165600@www.ageingandlongevity.org
SUMMARY:Early detection for dementia\, an oxymoron? Examining the evidence from population studies
DESCRIPTION:We’re delighted to invite you to an in‑person OSAL event with Professor Carol Brayne\, one of the leading public health voices in dementia and ageing. \nEarly detection for dementia is often treated as an obvious good: find it earlier\, fix it earlier. In this talk\, Professor Brayne will challenge that simple narrative\, drawing on decades of population‑based research to ask when dementia really becomes detectable\, what “early” labels actually tell us about the future\, and how screening can both help and harm. \nShe will explore: \n\nHow dementia trends have changed over time in real‑world populations\nWhy mild memory problems and “preclinical” labels do not always progress to dementia\nThe gap between tests/biomarkers and people’s lived cognitive function\nThe ethical and practical dilemmas of telling people they are “at risk” years before symptoms may—or may not—develop
URL:https://www.ageingandlongevity.org/event/early-detection-for-dementia-an-oxymoron-examining-the-evidence-from-population-studies/
LOCATION:David Smith Lecture Theatre\, Department of Pharmacology\, Mansfield Road\, Oxford OX1 3QT\, David Smith Lecture Theatre\, Department of Pharmacology\, Mansfield Road\,\, Oxford\, OX1 3QT
ATTACH;FMTTYPE=image/png:https://www.ageingandlongevity.org/wp-content/uploads/2026/03/EarlyDetectionForDementia.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260317T180000
DTEND;TZID=UTC:20260317T180000
DTSTAMP:20260608T191537
CREATED:20260312T113545Z
LAST-MODIFIED:20260312T113630Z
UID:1226-1773770400-1773770400@www.ageingandlongevity.org
SUMMARY:What do epigenetic clocks teach us about ageing and longevity?
DESCRIPTION:We’re delighted to invite you to an in‑person event with Professor Steve Horvath\, one of the world’s most influential ageing researchers and a principal investigator at Altos Labs. This event is co-hosted by the Oxford Society of Ageing and Longevity(OSAL) and the Consumer\, Media and Lifestyle OBN at Saïd Business School. \nThe development of DNA methylation-based epigenetic clocks has revolutionized our ability to measure biological age across tissues and species. In this talk\, Professor Horvath will synthesize insights from his foundational clocks\, such as PhenoAge and GrimAge\, to discuss what they reveal about individual ageing trajectories and how lifestyle\, environment\, and chronic disease accelerate biological ageing. He will also rigorously address the promise and limitations of these tools as surrogate endpoints in translational geroscience and anti-ageing clinical trials.
URL:https://www.ageingandlongevity.org/event/what-do-epigenetic-clocks-teach-us-about-ageing-and-longevity/
LOCATION:Rhodes Trust Lecture Theatre\, Oxford\, OX11HP
ATTACH;FMTTYPE=image/png:https://www.ageingandlongevity.org/wp-content/uploads/2026/03/EpigenetiC-ocksTeachUs.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260518T183000
DTEND;TZID=UTC:20260518T193000
DTSTAMP:20260608T191537
CREATED:20260517T122955Z
LAST-MODIFIED:20260517T123023Z
UID:1232-1779129000-1779132600@www.ageingandlongevity.org
SUMMARY:Taking Rejuvenation to Longevity Escape Velocity: Aubrey de Grey
DESCRIPTION:We are delighted to host Dr Aubrey de Grey\, President and Chief Science Officer of the Longevity Escape Velocity (LEV) Foundation\, for a live online talk with the Oxford Society of Ageing and Longevity. Dr de Grey is a biomedical gerontologist best known for pioneering the idea that ageing is a medically tractable condition and for his work on the SENS framework\, which targets the cellular and molecular damage that accumulates with age. \n​In this talk\, “Taking Rejuvenation to Longevity Escape Velocity”\, Dr de Grey will outline the scientific rationale and current progress toward therapies that may not only slow but potentially reverse aspects of biological ageing. He will discuss the concept of longevity escape velocity—the point at which advances in rejuvenation biotechnology extend healthy lifespan faster than time passes—and examine what scientific\, technological\, and translational milestones are needed to reach it. Drawing on his decades of work in biogerontology and advocacy for damage‑repair approaches\, he will also reflect on the opportunities and bottlenecks facing the longevity field today. \n​The event will be held online via Zoom at 6:30pm UK time\, featuring a 30‑minute presentation followed by an extended audience Q&A. The Oxford Society of Ageing and Longevity is a student‑led organisation highlighting cutting‑edge ageing research and rejuvenation biotechnology; this event is open to students\, researchers\, clinicians\, and anyone interested in the future of ageing science\, longevity biotechnology\, and the prospect of bringing ageing under medical control.
URL:https://www.ageingandlongevity.org/event/taking-rejuvenation-to-longevity-escape-velocity-aubrey-de-grey/
ATTACH;FMTTYPE=image/png:https://www.ageingandlongevity.org/wp-content/uploads/2026/05/Screenshot-2026-05-17-at-8.29.09-AM.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T170000
DTEND;TZID=UTC:20260610T183000
DTSTAMP:20260608T191537
CREATED:20260607T121620Z
LAST-MODIFIED:20260607T121620Z
UID:1236-1781110800-1781116200@www.ageingandlongevity.org
SUMMARY:Jonathan Wolf - ZOE: The reality of Health and AI in 2026
DESCRIPTION:​Oxford Society for Ageing and Longevity is delighted to welcome Jonathan Wolf\, co-founder and CEO of ZOE. Drawing on experience from building the world’s largest nutrition science study\, Jonathan will share what cutting-edge research is revealing about food\, gut health\, and AI\, and explore what these insights could mean for the future of healthcare innovation. \n​​Jonathan Wolf is the co-founder and CEO of ZOE\, a gut health science company that turns world-leading science into everyday gut-health products. \n​ZOE is famous for three products: its gut health supplement Daily30\, the ZOE app\, and its podcast\, ZOE Science + Nutrition\, which is the world’s #1 nutrition podcast. \n​ZOE also runs the world’s largest gut health science study\, publishing breakthrough research in some of the world’s most influential journals\, from The Lancet to Nature. \n​Before launching ZOE\, Jonathan was Chief Product Officer at Criteo\, helping the company grow from a 30-person startup to a NASDAQ-listed business with over $1B in revenue. Earlier in his career\, he worked at Yahoo. \n​Jonathan studied Physics at Oxford\, where he received the Gibbs Prize and served as President of the Oxford Union. He later studied at Harvard and is a Foundation Fellow at Corpus Christi College\, Oxford.
URL:https://www.ageingandlongevity.org/event/jonathan-wolf-zoe-the-reality-of-health-and-ai-in-2026/
LOCATION:Jesus College Oxford\, Jesus College\, Turl St\, Oxford\, OX1 3DW\, United Kingdom
ATTACH;FMTTYPE=image/png:https://www.ageingandlongevity.org/wp-content/uploads/2026/06/Screenshot-2026-06-07-at-8.13.07-AM.png
END:VEVENT
END:VCALENDAR